| 主 页 | 产品信息 | 工业应用 | 技术支持 | 维 修 | 联系我们 | 资料下载 |
| 食品工业应用 | |||||
|
Fermentation is widely used within the Pharmaceutical and Food industries. It requires the cultivation in submerged culture of an identified microorganism (mainly bacterial) as a monoculture under defined environmental conditions. The incubation regime imposed is designed to maximise the productivity of the organism of interest by providing optimal conditions for population growth (biomass). The product of interest might be a bioactive metabolite or recombinant protein. During an incubation cycle a nutrient energy source (e.g. glucose) is added and the biomass and end product will increase as this is depleted. Fermenter Design & Control
|
|||||
![]() |
|
||||
|
Temperature, pH, DO2 or Redox, agitation, pressure, foam control, auxiliary feed or a combination of these controllers. The control of these and any other parameters is most usually carried out in fermenter vessels specifically designed for the purpose and accommodating various working volumes depending on the yield and production requirements. Laboratory scale vessels could have a capacity of just 10 litres or less whereas production vessels may be as large as several thousand litres. The smallest units may incorporate an electrical heater and feed stocks (e.g. Nutrient and pH control agents) may be fed from flasks via peristaltic pumps. Larger vessels have an integral jacket for controlling temperature via hot or cold water and allowing indirect sterilisation using injected steam. Where larger quantities of feed stock are required they may be held in separate pressurised tanks and fed via a thrust pump arrangement of valves. The actual fermentation process is known as the Incubation Phase and is just part of the batch cycle. A complete fermentation cycle can typically include the following steps (depending on vessel design):
The R&D and Clinical Trials environments in which many small scale fermenters operate are such that it is not possible to predict the nature of any particular fermentation process either in terms of culture or incubation conditions. Production facilities must also cater for a variety of products each having precisely defined incubation profiles. A control system must therefore provide flexibility in the way in which accurate and repeatable control of the fermentation environment is achieved and will include the following features:
The Auditor feature on the Visual Supervisor has been specifically designed to meet the requirement of the FDAs 21 CFR Part 11 including:
With the Auditor feature, Electronic signature is configurable for all actions which may be performed form the Visual Supervisor display including the customised display and standard features such as batch, recipe changes, access control changes, etc. |
|||||
|
|||||
地址:辽宁省大连市中山区七七街23号海鹰大厦403室(116001) 电话:86-411-82597851;82650498 传真86-411-82650478 |
support@eurotherm.com.cn | |